共 38 条
Pectic Polysaccharides Isolated from Malian Medicinal Plants Protect against Streptococcus pneumoniae in a Mouse Pneumococcal Infection Model
被引:13
作者:
Inngjerdingen, K. T.
[1
]
Langerud, B. K.
[2
]
Rasmussen, H.
[3
,4
]
Olsen, T. K.
[3
,4
]
Austarheim, I.
[1
]
Gronhaug, T. E.
[1
]
Aaberge, I. S.
[2
]
Diallo, D.
[1
,5
]
Paulsen, B. S.
[1
]
Michaelsen, T. E.
[1
,2
]
机构:
[1] Univ Oslo, Sch Pharm, Dept Pharmaceut Chem, N-0316 Oslo, Norway
[2] Norwegian Inst Publ Hlth, Div Infect Dis Control, Dept Bacteriol & Immunol, Oslo, Norway
[3] Norwegian Inst Publ Hlth, Dept Lab Anim Serv, Div Publ Relat, Oslo, Norway
[4] Norwegian Inst Publ Hlth, Inst Resources, Oslo, Norway
[5] Dept Tradit Med, Bamako, Mali
基金:
欧盟第七框架计划;
关键词:
COLONY-STIMULATING FACTOR;
BIOPHYTUM-PETERSIANUM KLOTZSCH;
LUNG INFLAMMATION;
COLA-CORDIFOLIA;
MICE;
ACTIVATION;
RHAMNOGALACTURONAN;
CELLS;
HOMOGALACTURONAN;
MACROPHAGES;
D O I:
10.1111/sji.12047
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
The aim of this study was to investigate whether the pectic polysaccharides BP-II, Oc50A1.I.A and CC1P1 isolated from the Malian medicinal plants Biophytum petersianum, Opilia celtidifolia and Cola cordifolia, respectively, were able to protect against Streptococcus pneumoniae infection in mice. The pectin preparations were administered intraperitoneally 3h before challenge with S.pneumoniae serotype 6B. Blood samples were obtained from all animals before and at 3h, 24h and 72h after challenge with the pneumococci. The number of bacteria in blood was recorded and the blood concentration of a range of cytokines measured. The pretreatment with BP-II, Oc50A1.I.A and CC1P1 demonstrated a protective activity against S.pneumoniae serotype 6B infection, albeit at different range of concentrations. The pectins showed no direct antibacterial effects towards S.pneumonia; however, they induced the production of a range of cytokines and chemokines. We have previously shown that BP-II, Oc50A1.I.A and CC1P1 exhibit complement fixation activity and also that BP-II and Oc50A1.I.A stimulate macrophages to produce NO. The observed clinical effect might therefore be linked to the ability of the pectic polysaccharides to stimulate the innate immune system.
引用
收藏
页码:372 / 388
页数:17
相关论文